First author | Year | Country | Cancer | Total number | LncRNA XIST expression | Detection method | Cut-off (high/low) | Multivariate analysis | Survival analysis | HR and 95% CI | |
---|---|---|---|---|---|---|---|---|---|---|---|
High | Low | ||||||||||
Chen | 2016 | China | GC | 106 | 54 | 52 | qRT-PCR | 4.32 | No | OS | Report |
Song | 2016 | China | NPC | 108 | 76 | 32 | qRT-PCR | 2.31-fold | No | OS | SC |
Fang | 2016 | China | NSCLC | 53 | 38 | 15 | qRT-PCR | 2.58-fold | Yes | OS | Report |
Maa | 2016 | China | HCC | 68 | 30 | 38 | qRT-PCR | Mean | No | OS | SC |
Kobayashi | 2016 | Japan | CSCC | 49 | 24 | 25 | qRT-PCR | Median | No | OS | SC |
Mab | 2016 | China | GC | 98 | 45 | 53 | qRT-PCR | NA | No | OS | SC |
Zhang | 2017 | China | Osteosarcoma | 41 | 24 | 17 | qRT-PCR | Median | No | OS | SC |
Wu | 2017 | China | ESCC | 127 | 64 | 63 | qRT-PCR | Fold change | Yes | OS | Report |
Hu | 2017 | China | Bladder | 52 | 32 | 20 | qRT-PCR | Fold change | No | OS | SC |
Chen | 2017 | China | CRC | 115 | 58 | 57 | qRT-PCR | Median | Yes | OS | Report |
Duc | 2017 | China | Glioma | 69 | 35 | 34 | qRT-PCR | Median | Yes | OS | Report |
Wei | 2017 | China | PC | 64 | 32 | 32 | qRT-PCR | Median | Yes | OS | Report |
Dud | 2017 | China | PCa | 62 | 37 | 25 | qRT-PCR | Mean | No | OS | SC |
Li | 2017 | China | Osteosarcoma | 145 | 75 | 70 | qRT-PCR | NA | No | OS | SC |
Kong | 2017 | China | HCC | 52 | 26 | 26 | qRT-PCR | Median | No | OS | SC |